Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib

British Journal of Haematology

Volumn 161, Issue 1, 2013, Pages 150-153

  Follows, George A ^a   Sims, Hannah ^a   Bloxham, David M ^a   Zenz, Thorsten ^b   Hopper, Melanie A ^a   Liu, Hongxiang ^a   Bench, Anthony ^a   Wright, Penny ^a   van't Veer, Mars B ^a   Scott, Mike A ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

BRAF V600E; Hairy cell leukaemia; Vemurafenib

Indexed keywords

B RAF KINASE; BILIRUBIN; GLUTAMIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; VALINE; VEMURAFENIB;

AGED; ALLELE; BLOOD EXAMINATION; BONE MARROW BIOPSY; BRAF GENE; CASE REPORT; DRUG TOLERABILITY; ERYTHROCYTE TRANSFUSION; FLOW CYTOMETRY; GENE MUTATION; GENE SEQUENCE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERBILIRUBINEMIA; LETTER; LEUKOCYTOSIS; LOW DRUG DOSE; MALE; MUTATIONAL ANALYSIS; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEBORRHEIC KERATOSIS; THROMBOCYTE COUNT; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INDOLES; LEUKEMIA, HAIRY CELL; MALE; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; SULFONAMIDES;

EID: 84875055512     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12201     Document Type: Letter

References (5)

1. Boyd, E.M., Bench, A.J., van 't Veer, M.B., Wright, P., Bloxham, D.M., Follows, G.A. & Scott, M.A. (2011) High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies. British Journal of Haematology, 155, 609-612.
2. Chapman, P.B., Hauschild, A., Robert, C., Haanen, J.B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., Hogg, D., Lorigan, P., Lebbe, C., Jouary, T., Schadendorf, D., Ribas, A., O' Day, S.J., Sosman, J.A., Kirkwood, J.M., Eggermont, A.M., Dreno, B., Nolop, K., Li, J., Nelson, B., Hou, J., Lee, R.J., Flaherty, K.T., McArthur, G.A. & BRIM-3 Study Group. (2012) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. New England Journal of Medicine, 364, 2507-2516.
3. Dietrich, S., Glimm, H., Andrulis, M., von Kalle, C., Ho, A.D. & Zenz, T. (2012) BRAF inhibition in refractory hairy-cell leukemia. New England Journal of Medicine, 366, 2038-2040.
4. Mattei, P.L., Alora-Palli, M.B., Kraft, S., Lawrence, D.P., Flaherty, K.T. & Kimball, A.B. (2012) Cutaneous effects of BRAF inhibitor therapy: a case series. Annals of Oncology, doi: 10.1093/annonc/mds292.
5. Tiacci, E., Trifonov, V., Schiavoni, G., Holmes, A., Kern, W., Martelli, M.P., Pucciarini, A., Bigerna, B., Pacini, R., Wells, V.A., Sportoletti, P., Pettirossi, V., Mannucci, R., Elliott, O., Liso, A., Ambrosetti, A., Pulsoni, A., Forconi, F., Trentin, L., Semenzato, G., Inghirami, G., Capponi, M., Di Raimondo, F., Patti, C., Arcaini, L., Musto, P., Pileri, S., Haferlach, C., Schnittger, S., Pizzolo, G., Foà, R., Farinelli, L., Haferlach, T., Pasqualucci, L., Rabadan, R. & Falini, B. (2011) BRAF mutations in hairy-cell leukemia. New England Journal of Medicine, 64, 2305-2315.